Fortrea (NASDAQ:FTRE) Price Target Lowered to $11.00 at The Goldman Sachs Group
Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...
StockStory.org on MSN2d
Why Fortrea (FTRE) Shares Are Plunging Today
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after ...
Barclays Sticks to Its Hold Rating for Fortrea Holdings Inc. (FTRE)
In a report released today, Luke Sergott from Barclays maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report), with a price ...
Fortrea (NASDAQ:FTRE) Price Target Cut to $12.00 by Analysts at Barclays
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
Nasdaq3d
FORTREA Earnings Results: $FTRE Reports Quarterly Earnings
FORTREA ($FTRE) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.18 per share, missing estimates of $0.37 by $0.19. The ...
Benzinga.com2d
Fortrea Holdings (NASDAQ:FTRE) Stock, Short Interest Report
Short interest in Fortrea Holdings Inc (NASDAQ:FTRE) increased during the last reporting period, rising from 5.92M to 6.10M. This put 9.81% of the company's publicly available shares short.
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Evolus (EOLS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fortrea Holdings Inc. (FTRE – Research ...